Charlotte, North Carolina-based Albemarle Corporation (ALB) develops, manufactures, and markets engineered specialty chemicals for mobility, energy, connectivity, and health solutions. With a market cap of $9.6 billion, the company offers critical ingredients used in grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical devices.
Companies worth $2 billion or more are generally described as “mid-cap stocks,” and ALB perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the specialty chemicals industry. Albemarle's diversified portfolio is a strength, with its leadership in lithium, bromine specialties, and catalysts providing resilience and cross-selling opportunities, while vertical integration in lithium shields it from raw material price volatility.
